These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19010635)

  • 1. C-kit protein expression in Wilms' tumour: an immunohistochemical study.
    Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G
    Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy.
    Diniz G; Aktas S; Ortac R; Tunakan M; Unlu I; Vergin C
    Pathol Res Pract; 2006; 202(9):671-7. PubMed ID: 16860492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
    Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and localization of HGF and met in Wilms' tumours.
    Alami J; Williams BR; Yeger H
    J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of c-kit in Ewing family of tumors: a comparison of different immunohistochemical protocols.
    Ahmed A; Gilbert-Barness E; Lacson A
    Pediatr Dev Pathol; 2004; 7(4):342-7. PubMed ID: 15383930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of VEGF-C/VEGFR-2 interaction in the neovascularization and prognosis of nephroblastoma (Wilms' tumour).
    Nowicki M; Ostalska-Nowicka D; Kaczmarek M; Miskowiak B; Witt M
    Histopathology; 2007 Feb; 50(3):358-64. PubMed ID: 17257131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Cox-2 expression in Wilms' tumor.
    Giordano G; Campanini N; Donofrio V; Bertolini P; Falleti J; Grassani C; Pettinato G
    Pathol Res Pract; 2008; 204(12):875-82. PubMed ID: 18752906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of gamma catenin in Wilms' tumors.
    Basta-Jovanovic G; Gvozdenovic E; Dimitrijevic I; Brasanac D; Jovanovic M; Kalezic N; Baralic I; Radojevic-Skodric S; Arsic D
    Fetal Pediatr Pathol; 2008; 27(2):63-70. PubMed ID: 18568994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
    Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
    Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of proliferating cell nuclear antigen in Wilms' tumour in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kantorowicz S; Daszkiewicz P
    Eur J Surg Oncol; 2002 Feb; 28(1):67-71. PubMed ID: 11869017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of p53 expression in Wilms' tumor in children.
    Skotnicka-Klonowicz G; Kobos J; Łoś E; Trejster E; Szymik-Kontorowicz S; Daszkiewicz P
    Med Sci Monit; 2001; 7(6):1224-9. PubMed ID: 11687734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma.
    Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Van den Heuvel MM; Noordzij MA; Nijman RJ; Soliman EH; van Steenbrugge GJ
    Br J Cancer; 2001 Nov; 85(10):1557-63. PubMed ID: 11720445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of KIT expression in small cell lung cancer.
    López-Martin A; Ballestín C; Garcia-Carbonero R; Castaño A; Lopez-Ríos F; López-Encuentra A; Sánchez-Cespedes M; Castellano D; Bartolomé A; Cortés-Funes H; Paz-Ares L
    Lung Cancer; 2007 Jun; 56(3):405-13. PubMed ID: 17420067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anaplastic type of Wilms' tumour].
    Vujanić GM; Aleksandrović S
    Srp Arh Celok Lek; 1990; 118(9-10):353-6. PubMed ID: 1966350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
    Cheah PL; Looi LM; Chan LL
    Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: a report from the SIOP 93-01 nephroblastoma trial and study.
    Ora I; van Tinteren H; Bergeron C; de Kraker J;
    Eur J Cancer; 2007 Jan; 43(1):131-6. PubMed ID: 17084075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 expression in Wilms' tumor: a possible role as prognostic factor.
    Beniers AJ; Efferth T; Füzesi L; Granzen B; Mertens R; Jakse G
    Int J Oncol; 2001 Jan; 18(1):133-9. PubMed ID: 11115550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of KIT (CD117) expression in gallbladder carcinomas by tissue microarray.
    Langner C; Lemmerer M; Kornprat P
    Eur J Surg Oncol; 2004 Oct; 30(8):847-50. PubMed ID: 15336730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.